{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:03:12Z","timestamp":1795068192347,"version":"4.10.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20921-x","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:37:45Z","timestamp":1761125865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics and in vivo efficacy of epetraborole against Burkholderia pseudomallei"],"prefix":"10.1038","volume":"15","author":[{"given":"Jason E.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danara","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R. K.","family":"Alley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Slayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20921_CR1","unstructured":"Meliodosis, C. & December, S. Melioidosis Case Definition, Reporting, and (2024). Available from: https:\/\/www.cdc.gov\/melioidosis\/php\/surveillance\/index.html#:~:text=Laboratory%20Notification,local%20public%20health%20department%20immediately."},{"issue":"3","key":"20921_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/QCO.0000000000000827","volume":"35","author":"E Birnie","year":"2022","unstructured":"Birnie, E., Biemond, J. J. & Wiersinga, W. J. Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change. Curr. Opin. Infect. Dis. 35 (3), 196\u2013204. https:\/\/doi.org\/10.1097\/QCO.0000000000000827 (2022).","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"20921_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2015.8","volume":"1","author":"D Limmathurotsakul","year":"2016","unstructured":"Limmathurotsakul, D. et al. Predicted global distribution of burkholderia Pseudomallei and burden of melioidosis. Nat. Microbiol. 1 (1), 1. https:\/\/doi.org\/10.1038\/nmicrobiol.2015.8 (2016).","journal-title":"Nat. Microbiol."},{"issue":"11","key":"20921_CR4","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","volume":"4","author":"BJ Currie","year":"2010","unstructured":"Currie, B. J., Ward, L. & Cheng, A. C. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl. Trop. Dis. 4 (11), e900. https:\/\/doi.org\/10.1371\/journal.pntd.0000900 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"20921_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJMra1204699","volume":"367","author":"WJ Wiersinga","year":"2012","unstructured":"Wiersinga, W. J., Currie, B. J., Peacock, S. J. & Melioidosis N Engl. J. Med. ;367(11):1035\u20131044. doi: https:\/\/doi.org\/10.1056\/NEJMra1204699. (2012).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"20921_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12941-023-00620-z","volume":"22","author":"K Keragala","year":"2023","unstructured":"Keragala, K., Gunathilaka, M., Senevirathna, R. & Jayaweera, J. Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review. Ann. Clin. Microbiol. Antimicrob. 22 (1), 74. https:\/\/doi.org\/10.1186\/s12941-023-00620-z (2023).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"12","key":"20921_CR7","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3201\/eid1812.120638","volume":"18","author":"R Lipsitz","year":"2012","unstructured":"Lipsitz, R. et al. Workshop on treatment of and postexposure prophylaxis for burkholderia Pseudomallei and B. mallei Infection, 2010. Emerg. Infect. Dis. 18 (12), e2. https:\/\/doi.org\/10.3201\/eid1812.120638 (2012).","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"20921_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","volume":"43","author":"D Dance","year":"2014","unstructured":"Dance, D. Treatment and prophylaxis of melioidosis. Int. J. Antimicrob. Agents. 43 (4), 310\u2013318. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.005 (2014).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"20921_CR9","doi-asserted-by":"publisher","first-page":"dlac028","DOI":"10.1093\/jacamr\/dlac028","volume":"4","author":"JE Cummings","year":"2022","unstructured":"Cummings, J. E., Abdo, Z. & Slayden, R. A. Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against category A and B priority pathogens. JAC Antimicrob. Resist. 4 (2), dlac028. https:\/\/doi.org\/10.1093\/jacamr\/dlac028 (2022).","journal-title":"JAC Antimicrob. Resist."},{"issue":"1","key":"20921_CR10","doi-asserted-by":"publisher","first-page":"e0005209","DOI":"10.1371\/journal.pntd.0005209","volume":"11","author":"JE Cummings","year":"2017","unstructured":"Cummings, J. E. & Slayden, R. A. Transient in vivo resistance mechanisms of burkholderia Pseudomallei to Ceftazidime and molecular markers for monitoring treatment response. PLoS Negl. Trop. Dis. 11 (1), e0005209. https:\/\/doi.org\/10.1371\/journal.pntd.0005209 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"20921_CR11","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.jinf.2023.03.022","volume":"86","author":"PH Wu","year":"2023","unstructured":"Wu, P. H. et al. Emergence of meropenem and Levofloxacin resistance in burkholderia Pseudomallei in Taiwan. J. Infect. 86 (6), e161\u2013e3. https:\/\/doi.org\/10.1016\/j.jinf.2023.03.022 (2023).","journal-title":"J. Infect."},{"issue":"1\u20132","key":"20921_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4269\/ajtmh.2001.64.24","volume":"64","author":"P Chetchotisakd","year":"2001","unstructured":"Chetchotisakd, P., Chaowagul, W., Mootsikapun, P., Budhsarawong, D. & Thinkamrop, B. Maintenance therapy of melioidosis with Ciprofloxacin plus Azithromycin compared with Cotrimoxazole plus Doxycycline. Am. J. Trop. Med. Hyg. 64 (1\u20132), 24\u201327. https:\/\/doi.org\/10.4269\/ajtmh.2001.64.24 (2001).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"11","key":"20921_CR13","doi-asserted-by":"publisher","first-page":"O854","DOI":"10.1111\/1469-0691.12614","volume":"20","author":"D Limmathurotsakul","year":"2014","unstructured":"Limmathurotsakul, D. et al. Role of burkholderia Pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Clin. Microbiol. Infect. 20 (11), O854\u2013O856. https:\/\/doi.org\/10.1111\/1469-0691.12614 (2014).","journal-title":"Clin. Microbiol. Infect."},{"issue":"9","key":"20921_CR14","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1128\/JCM.01219-14","volume":"52","author":"D Limmathurotsakul","year":"2014","unstructured":"Limmathurotsakul, D. et al. Microevolution of burkholderia Pseudomallei during an acute infection. J. Clin. Microbiol. 52 (9), 3418\u20133421. https:\/\/doi.org\/10.1128\/JCM.01219-14 (2014).","journal-title":"J. Clin. Microbiol."},{"issue":"11","key":"20921_CR15","doi-asserted-by":"publisher","first-page":"e0011795","DOI":"10.1371\/journal.pntd.0011795","volume":"17","author":"JE Cummings","year":"2023","unstructured":"Cummings, J. E., Lunde, C. S., Alley, M. R. K. & Slayden, R. A. Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of Ceftazidime against burkholderia pseudomallei, the causative agent of melioidosis. PLoS Negl. Trop. Dis. 17 (11), e0011795. https:\/\/doi.org\/10.1371\/journal.pntd.0011795 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"20921_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics12030506","volume":"12","author":"M Nelson","year":"2023","unstructured":"Nelson, M. et al. The BALB\/c mouse model for the evaluation of therapies to treat infections with aerosolized burkholderia Pseudomallei. Antibiot. (Basel). 12 (3), 1. https:\/\/doi.org\/10.3390\/antibiotics12030506 (2023).","journal-title":"Antibiot. (Basel)"},{"issue":"5","key":"20921_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0300985813486812","volume":"50","author":"MV Stundick","year":"2013","unstructured":"Stundick, M. V. et al. Animal models for Francisella tularensis and burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA animal rule. Vet. Pathol. 50 (5), 877\u2013892 (2013).","journal-title":"Vet. Pathol."},{"issue":"1","key":"20921_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1086\/510079","volume":"44","author":"PG Ambrose","year":"2007","unstructured":"Ambrose, P. G. et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it\u2019s not just for mice anymore. Clin. Infect. Dis. 44 (1), 79\u201386 (2007).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"20921_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/infdis\/168.5.1181","volume":"168","author":"W Chaowagul","year":"1993","unstructured":"Chaowagul, W. et al. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168 (5), 1181\u20131185 (1993).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"20921_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1128\/AAC.02058-12","volume":"57","author":"V Hernandez","year":"2013","unstructured":"Hernandez, V. et al. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Antimicrob. Agents Chemother. 57 (3), 1394\u20131403. https:\/\/doi.org\/10.1128\/AAC.02058-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"20921_CR21","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1128\/AAC.02483-12","volume":"57","author":"D Tenero","year":"2013","unstructured":"Tenero, D. et al. Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers. Antimicrob. Agents Chemother. 57 (7), 3334\u20133339. https:\/\/doi.org\/10.1128\/AAC.02483-12 (2013).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20921-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:37:46Z","timestamp":1761125866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20921-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20921-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36865"}}